The Effect of Osteopontin and an Osteopontin-Derived Synthetic Peptide Coating on Osseointegration of Implants in a Canine Model
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Fiorellini, Joseph P. | - |
dc.contributor.author | Glindmann, Sven | - |
dc.contributor.author | Salcedo, Jairo | - |
dc.contributor.author | Weber, Hans-Peter | - |
dc.contributor.author | Park, Chang-Joo | - |
dc.contributor.author | Sarmiento, Hector L. | - |
dc.date.accessioned | 2022-07-15T04:20:34Z | - |
dc.date.available | 2022-07-15T04:20:34Z | - |
dc.date.created | 2021-05-12 | - |
dc.date.issued | 2016-11 | - |
dc.identifier.issn | 0198-7569 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/153630 | - |
dc.description.abstract | Osteopontin (OPN) and an OPN-derived synthetic peptide, OC-1016, have demonstrated their potential to enhance osseointegration in vitro. The purpose of this study was to evaluate bone-to-implant contact (BIC) and surrounding bone density (BD) of implants coated with either recombinant human OPN (rhOPN) or OC-1016 as compared with noncoated titanium plasma sprayed (TPS) surface in a canine model. Histomorphometric analysis revealed that at 4 weeks, % BIC and % BD of coated implants were signiicantly higher than those of noncoated TPS implants. At 12 weeks, % BIC of coated implants was also signiicantly higher than that of noncoated implants; however, there was no statistically signiicant difference in % BD. The rhOPN and OC-1016 were concluded to be capable of signiicantly accelerating the early stage of osseointegration and bone healing around implants. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | Quintessence Publishing Company | - |
dc.title | The Effect of Osteopontin and an Osteopontin-Derived Synthetic Peptide Coating on Osseointegration of Implants in a Canine Model | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Park, Chang-Joo | - |
dc.identifier.doi | 10.11607/prd.2830 | - |
dc.identifier.scopusid | 2-s2.0-84998780456 | - |
dc.identifier.wosid | 000387129800001 | - |
dc.identifier.bibliographicCitation | International Journal of Periodontics and Restorative Dentistry, v.36, no.6, pp.E88 - E94 | - |
dc.relation.isPartOf | International Journal of Periodontics and Restorative Dentistry | - |
dc.citation.title | International Journal of Periodontics and Restorative Dentistry | - |
dc.citation.volume | 36 | - |
dc.citation.number | 6 | - |
dc.citation.startPage | E88 | - |
dc.citation.endPage | E94 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Dentistry, Oral Surgery & Medicine | - |
dc.relation.journalWebOfScienceCategory | Dentistry, Oral Surgery & Medicine | - |
dc.subject.keywordPlus | TITANIUM IMPLANTS | - |
dc.subject.keywordPlus | PROSPECTIVE MULTICENTER | - |
dc.subject.keywordPlus | BONE-FORMATION | - |
dc.subject.keywordPlus | FOLLOW-UP | - |
dc.subject.keywordPlus | SURFACES | - |
dc.subject.keywordPlus | CELLS | - |
dc.subject.keywordPlus | HYDROXYAPATITE | - |
dc.subject.keywordPlus | COLLAGEN | - |
dc.subject.keywordPlus | PROLIFERATION | - |
dc.subject.keywordPlus | EXPRESSION | - |
dc.identifier.url | http://quintpub.com/journals/prd/abstract.php?iss2_id=1405&article_id=16729&article=10&title=The%20Effect%20of%20Osteopontin%20and%20an%20Osteopontin-Derived%20Synthetic%20Peptide%20Coating%20on%20Osseointegration%20of%20Implants%20in%20a%20Canine%20Model#.YRIsU4gzbct | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1365
COPYRIGHT © 2021 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.